| New Data on Odanacatib, Merck's Investigational Cathepsin-K Inhibitor for ... - MarketWatch (press release) |
|
|
MarketWatch (press release)Renal Insufficiency: Preclinical studies show that, in rats with kidney failure, increasing amounts of drug are present in plasma, kidney, spleen, ... read more |